Sugi Predict

Sugi Predict / Compounds / SCHEMBL1891552

SCHEMBL1891552

SCHEMBL1891552

CCOC(=O)n1nc(NC(=O)c2ccc(N3CCN(C)CC3)cc2[N+](=O)[O-])c2c1CCN(S(=O)(=O)c1cccc(OC)c1)C2

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ HTT P42858 2/20 0.40
▸ SIRT6 Q8N6T7 3/20 0.39
▸ IGF1R P08069 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ LMNA P02545 2/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ APOBEC3A P31941 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ APOBEC3G Q9HC16 1/20 0.37
▸ WDR5 P61964 1/20 0.36
▸ MGLL Q99685 1/20 0.36
▸ PTPN11 Q06124 2/20 0.36
▸ HTR6 P50406 1/20 0.36
▸ MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1890266 0.92 SIRT6 (0.42) L3MBTL1HTTSIRT6IGF1RALDH1A1
SCHEMBL1891290 0.92 IGF1R (0.45) L3MBTL1HTTSIRT6IGF1RLMNA
SCHEMBL1891150 0.92 HTT (0.40) L3MBTL1HTTSIRT6IGF1RALDH1A1
SCHEMBL1894300 0.89 IGF1R (0.40) HTTSIRT6IGF1RALDH1A1LMNA
SCHEMBL1894731 0.89 IGF1R (0.50) L3MBTL1HTTSIRT6IGF1RLMNA
SCHEMBL1892503 0.89 TMEM97 (0.44) L3MBTL1HTTSIRT6IGF1RLMNA
SCHEMBL1889278 0.88 MAPT (0.41) L3MBTL1HTTSIRT6IGF1RALDH1A1
SCHEMBL1885344 0.86 IGF1R (0.40) HTTSIRT6IGF1RALDH1A1TP53
SCHEMBL1891125 0.85 SIRT6 (0.43) SIRT6IGF1RALDH1A1LMNAHTR6
SCHEMBL1885175 0.83 IGF1R (0.38) L3MBTL1HTTIGF1RALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173659-B2 Substituted pyrazolo[4,3-C]pyridine derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-05-08 — — US disclosed
US-20110230470-A1 SUBSTITUTED PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-09-22 — — US disclosed
US-7947686-B2 Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-05-24 — — US disclosed
US-20090023745-A1 Substituted Pyrazolo[4,3-c]Pyridine Derivatives Active as Kinase Inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-01-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230470-A1 SUBSTITUTED PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS MAP3K3, MAP3K1, MAP3K19 L3MBTL1 3525/4885HTT 4780/4885SIRT6 1409/4885
US-20090023745-A1 Substituted Pyrazolo[4,3-c]Pyridine Derivatives Active as Kinase Inhibitors MAP3K3, MAP3K1, MAP3K19 L3MBTL1 3525/4885HTT 4780/4885SIRT6 1409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.